The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

Drug shortages threaten lives—cancer patients cannot wait

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

The shortage of certain cancer drugs is a serious and life-threatening issue for cancer patients across the United States. This, however, is not a new issue. Drug shortages are a cyclical event, and we need a durable solution to ensure that cancer patients have access to the drugs and the treatment they need to survive. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Karen E. Knudsen, PhD, MBA
Chief executive officer, American Cancer Society, American Cancer Society Cancer Action Network
Table of Contents

YOU MAY BE INTERESTED IN

Conversation with The Cancer Letter

ACS, ASCO combine online patient information services

The American Cancer Society and the American Society of Clinical Oncology have combined their cancer information resources, which will be available at no cost to the public on cancer.org. The collaboration, which combines the two organizations’ sites—ACS’s cancer.org and ASCO’s cancer.net—was announced at the 2024 ASCO Annual Meeting in Chicago May 1. Cancer.org is now...

By Paul Goldberg
Byline
Karen E. Knudsen, PhD, MBA
Chief executive officer, American Cancer Society, American Cancer Society Cancer Action Network
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account